Login

The pandemic accelerated our focus on operational resilience and digital transformation. 00:10:00

Share On Facebook Share On Twitter

Doron Blachar is Chief Executive Officer, Ormat Technologies Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Scotiabank CEO Reflects on Strong Finish and Strategic Shifts for Future Growth | Brian Porter, CEO, Scotiabank.
00:10:00
Investment Strategy in Uranium: A Supply-Demand Mismatch
00:10:00
Beacon Financial Strategies: Fee-Only Advisory for Transparent and Client-Centric Planning
00:10:00
Navigating a Bear Market: Insights from Allodium Investment Consultants
00:10:00
Chris Heckert of Generational Capital Markets discusses strategic mergers and acquisitions, focusing on valuation and deal execution on MandA.TV.
00:10:00
Conversations with David Solomon and Thomas Tull: From Hamilton College to Entrepreneurship and Innovation | David Solomon, CEO, Goldman Sachs.
00:10:00
The Startup Gamble: How to Invest in Early-Stage Companies for Explosive Growth|Oana Olteanu,Partner,SignalFire
00:10:00
Abhishek Bansal Discusses Strategy, Innovation, and the Future of Abans Holdings | Abhishek Bansal , CEO , Abans Holdings Ltd.
00:10:00
Predictive Modeling and Mapping in Germany’s Erzgebirge Region: A Technical Overview
00:00:00
Imugene progresses onCARlytics solid tumour trial to combination arm - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
serving a large addressable market by the potential|Gary Benitt,Managing Partner,Social Leverage
00:10:00
Strategic Investment Insights on Inflation and Real Assets

© 2017 - Neuhu+